Highnoon Laboratories (KAR:HINOON) Other Current Receivables: ₨185 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KAR:HINOON Highnoon Laboratories Ltd KAR:HINOON
96 GF Score
Price ₨1,003.54
GF Value ₨1,030.52
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Highnoon Laboratories Other Current Receivables?

Highnoon Laboratories KAR:HINOON +0.86% 96 Other Current Receivables is ₨185 Mil as of Mar. 2026. GuruFocus rates KAR:HINOON with a GF Score™ of 96/100 and a GF Value™ of ₨1,030.52 (Fairly Valued). The stock has 3 warning signs investors should review.

Highnoon Laboratories's Other Current Receivables for the quarter that ended in Mar. 2026 was ₨185 Mil.

Highnoon Laboratories's quarterly Other Current Receivables declined from Sep. 2025 (₨34.45 Mil) to Dec. 2025 (₨5.60 Mil) but then increased from Dec. 2025 (₨5.60 Mil) to Mar. 2026 (₨184.96 Mil).

Highnoon Laboratories's annual Other Current Receivables increased from Dec. 2023 (₨12.23 Mil) to Dec. 2024 (₨25.89 Mil) but then declined from Dec. 2024 (₨25.89 Mil) to Dec. 2025 (₨5.60 Mil).

Highnoon Laboratories Other Current Receivables Related Terms

Highnoon Laboratories Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Highnoon Laboratories's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Highnoon Laboratories Other Current Receivables Chart

Highnoon Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.75 25.69 12.23 25.89 5.60

Highnoon Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.63 203.87 34.45 5.60 184.96
KAR:HINOON
96GF Score
Highnoon Laboratories Ltd KAR:HINOON
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Highnoon Laboratories Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₨185 Mil mean?
Highnoon Laboratories (KAR:HINOON) has a Other Current Receivables of ₨185 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Highnoon Laboratories and its competitors.
Is Highnoon Laboratories' Other Current Receivables too high?
Highnoon Laboratories' current Other Current Receivables is ₨185 Mil. Overall, Highnoon Laboratories has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Highnoon Laboratories' Other Current Receivables compare to LLY and JNJ?
Highnoon Laboratories' Other Current Receivables of ₨185 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Drug Manufacturers company?
A good Other Current Receivables depends on the Drug Manufacturers industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Highnoon Laboratories and its competitors. Highnoon Laboratories's current Other Current Receivables is ₨185 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Highnoon Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Highnoon Laboratories (KAR:HINOON) is currently considered Fairly Valued. The stock's GF Value™ is ₨1,030.52, compared to a current price of ₨1,003.54 — trading 2.6% below its estimated fair value. The current Other Current Receivables is ₨185 Mil. Highnoon Laboratories' overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Highnoon Laboratories (KAR:HINOON), the current Other Current Receivables is ₨185 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Highnoon Laboratories (KAR:HINOON) Overvalued in 2026?

Based on GuruFocus' analysis, Highnoon Laboratories stock appears to be undervalued. The current stock price of ₨1,003.54 is trading 2.6% below its estimated GF Value™ of ₨1,030.52. GuruFocus considers Highnoon Laboratories to be Fairly Valued.

Key valuation signals for KAR:HINOON:

  • Other Current Receivables: ₨185 Mil
  • GF Value™: ₨1,030.52 vs. price of ₨1,003.54 (2.6% below fair value)
  • GF Score™: 96/100 with 3 warning signs

No single metric tells the full story. See the KAR:HINOON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Highnoon Laboratories Business Description

Address Jail Road, 901-9th floor, Tricon Corporate Center 73-E, Lahore, PAK
Highnoon Laboratories Ltd is a company engaged in the manufacture, import, sale, and marketing of pharmaceutical and allied consumer products. It focuses on the alimentary tract and metabolism, antihistamines, anti-infectives, cardiovascular, endocrine, hematology, musculoskeletal, nervous system, parasitology, respiratory, and urinary. Its products include AIRTAL (Aceclofenac); ARIA (ketotifen); ARTECXCIN, and artrodar (diacerein). Its other products include Asthavent, AXESOME, Bezisox, Betatec, and many more.
96GF Score

Get the complete analysis for KAR:HINOON

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨1,003.54
Price
₨1,030.52
GF Value